Related Experiment Videos
Gene therapy for malignant liver disease.
Leonhard Mohr1, Michael Geissler, Hubert E Blum
1Department of Medicine II, University Hospital Freiburg, Hugstetter Strasse 55, D-79106 Freiburg, Germany. mohrl@sun11.ukl.uni-freiburg.de
Expert Opinion on Biological Therapy
|February 19, 2002
Summary
Gene therapy offers novel treatment strategies for advanced liver cancer (hepatocellular carcinoma) and metastatic liver disease. While current trials show limited effects, ongoing improvements in gene delivery and therapeutic approaches hold promise for future clinical applications.
Area of Science:
- Oncology
- Hepatology
- Gene Therapy
Background:
- Limited treatment options and poor prognosis for advanced/multifocal hepatocellular carcinoma (HCC) and metastatic liver disease.
- Urgent need for novel therapeutic strategies, including gene therapy, for malignant liver tumors.
Purpose of the Study:
- To review current gene therapy approaches for treating liver cancer.
- To highlight the potential of gene therapy in improving outcomes for patients with advanced liver malignancies.
Main Methods:
- Gene delivery systems (vectors) introduce therapeutic DNA constructs into cells.
- Strategies include reintroducing tumor suppressor genes, expressing foreign enzymes, enhancing immunogenicity, and anti-angiogenesis.
- Development of oncolytic viruses that selectively replicate in tumor cells.
Main Results:
- Current clinical trials of antitumour gene therapy have not yet demonstrated strong therapeutic effects.
- Gene therapy offers diverse mechanisms to combat liver tumors, including direct cell killing and inhibiting tumor growth.
Conclusions:
- Despite current limitations, advancements in gene therapy hold potential for future effective clinical treatments for liver cancer.
- Further research and development are crucial to realize the full therapeutic potential of gene therapy in oncology.